Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1996Journal of VirologyOpen Access

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

View Full Paper
Ask AI
Bookmark
Share

Authors

ATAlexandra TrkolaUniversity of ZurichMPMartin PurtscherTakeda (Austria)TMThomas MusterAustrian Competence Centre of Food Safety

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Trkola et al. (1996) studied this question.

synapsesocial.com/papers/6a20011235281a23f90dc3cbhttps://doi.org/10.1128/jvi.70.2.1100-1108.1996
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates1995 · 295 citations
  2. 2Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.1987 · 216 citations
  3. 3Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding1993 · 633 citations
  4. 4Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection1995 · 1,044 citations
  5. 5Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.1989 · 620 citations